Commencement of Trading on US OTCQB Venture Market

AI SummaryClose X

Coiled Therapeutics plc has commenced trading on the US OTCQB Venture Market under the ticker COTXF, in addition to its existing AIM listing (COIL), aiming to broaden its investor base and enhance share liquidity. This move allows US investors access during US business hours, priced in US dollars, without imposing additional reporting obligations or significant costs due to its Foreign Private Issuer status and exemption under SEC Rule 12g3-2(b). The company also highlighted encouraging clinical data from Cohort 4b of its ongoing trial, showing an 80% Clinical Benefit Rate and durable responses in heavily pre-treated patients, with dose escalation expected to complete in H1 2026.

Disclaimer*

UK 100

Latest directors dealings